Herbas VPB

Print
EN | LT
LT - FORMULATION COMPRISING FENFLURAMINE AND CANNABIDIOL AND ITS USE IN THE TREATMENT OF SEIZURES
EN - FORMULATION COMPRISING FENFLURAMINE AND CANNABIDIOL AND ITS USE IN THE TREATMENT OF SEIZURES

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 45/06 (2006.01)
A61K 45/06 (2013.01)
A61K 31/05 (2006.01)
A61K 31/36 (2013.01)
A61K 31/137 (2006.01)
A61K 31/551 (2013.01)
A61K 31/36 (2006.01)
A61K 31/05 (2013.01)
A61K 31/551 (2006.01)
A61K 31/137 (2013.01)
A61P 3/04 (2006.01)
A61P 25/00 (2018.01)
A61P 25/08 (2006.01)
A61P 25/08 (2018.01)
A61P 3/04 (2018.01)
A61P 43/00 (2018.01)
European patent
(11) Number of the document 3518975
(13) Kind of document T
(96) European patent application number 17772094.3
Date of filing the European patent application 2017-08-02
(97) Date of publication of the European application 2019-08-07
(45) Date of publication and mention of the grant of the patent 2025-04-09
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/IB2017/054740
Date 2017-08-02
PCT application publication
(87) Number WO 2018/037306
Date 2018-03-01
Priority applications
(30) Number Date Country code
201662379183 P 2016-08-24 US
201762515383 P 2017-06-05 US
Inventors
(72)
FARR, Stephen J. , US
BOYD, Brooks , US
Grantee
(73) Zogenix International Limited , Windlesham Campus, Sunninghill Road, Windlesham, Surrey GU20 6PP, GB
Title
(54) FORMULATION COMPRISING FENFLURAMINE AND CANNABIDIOL AND ITS USE IN THE TREATMENT OF SEIZURES
  FORMULATION COMPRISING FENFLURAMINE AND CANNABIDIOL AND ITS USE IN THE TREATMENT OF SEIZURES